News
COR
360.00
-0.90%
-3.27
Cencora Updates Segment Reporting Following Strategic Business Review
TipRanks · 8h ago
Cencora price target raised to $419 from $417 at JPMorgan
TipRanks · 10h ago
Cencora price target raised to $429 from $405 at Wells Fargo
TipRanks · 10h ago
What Are Wall Street Analysts' Target Price for Cencora Stock?
Barchart · 15h ago
Weekly Report: what happened at COR last week (0202-0206)?
Weekly Report · 1d ago
Cencora: OneOncology Acquisition and Conservative Guidance Underscore Upside to $400 Target
TipRanks · 1d ago
Cardinal Health surges following quarterly earnings beats, guidance raise
Seeking Alpha · 5d ago
Cencora (COR) Stock Trades Up, Here Is Why
Barchart · 5d ago
Cencora price target lowered to $420 from $440 at Evercore ISI
TipRanks · 5d ago
Cencora (COR) Gets a Buy from Barclays
TipRanks · 5d ago
Cencora Earnings Call: Specialty Strength, Guidance Raised
TipRanks · 5d ago
Cencora Inc. stock underperforms Wednesday when compared to competitors
MarketWatch · 6d ago
Cencora outlines 11.5%-13.5% operating income growth for 2026 while integrating OneOncology
Seeking Alpha · 6d ago
Broader Market Falls as Chipmakers and AI Stocks Tumble
Barchart · 6d ago
Cencora Completes OneOncology Acquisition, Lifts Guidance
TipRanks · 6d ago
Cencora declares $0.60 dividend
Seeking Alpha · 6d ago
Cencora reports Q1 adjusted EPS $4.08, consensus $4.04
TipRanks · 6d ago
Cencora backs FY26 adjusted EPS view $17.45-$17.75, consensus $17.59
TipRanks · 6d ago
Cencora sees FY26 adjusted free cash flow about $3B; FY26 CapEx $900M
TipRanks · 6d ago
Cencora gives mixed Q1 results, reaffirms guidance
Seeking Alpha · 6d ago
More
Webull provides a variety of real-time COR stock news. You can receive the latest news about Cencora Inc. through multiple platforms. This information may help you make smarter investment decisions.
About COR
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.